Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI.
Imperial College London
282 participants
Aug 1, 2014
INTERVENTIONAL
Conditions
Summary
Eligible patients with high risk colorectal malignancy (T3/4, spread greater than 5mm, EMVI positive) will have additional surveillance of breath hold T1, T2 and DW-MRIs (no IV contrast) post surgery six monthly for three years. Findings of liver MRIs as reported by radiology PI will be shared with their local MDT who make decisions as appropriate, including the management of any identified liver metastases, according to local protocol.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Liver metastases found on the additional DW-MRI scans will be discussed at MDT and treated according to local site policy.
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02246634